Industries - Next Generation Sequencing (NGS) Services Market Analysis by Sequencing Type, by Application (Clinical Investigation, Oncology, Immune System Monitoring), by Process Flow Type (Pre-Sequencing, Sequencing, Data Analysis), by End-Use & by Region – Forecast to 2026

Ablation Technology Market Analysis

Next Generation Sequencing (NGS) Services Market Analysis by Sequencing Type, by Application (Clinical Investigation, Oncology, Immune System Monitoring), by Process Flow Type (Pre-Sequencing, Sequencing, Data Analysis), by End-Use & by Region – Forecast to 2026
March 2021

SKU: N/A Category:
Clear
  • Description
  • Additional information
  • Enquire about

Description

Next Generation Sequencing (NGS) Services Market Analysis by Sequencing Type, by Application (Clinical Investigation, Oncology, Immune System Monitoring), by Process Flow Type (Pre-Sequencing, Sequencing, Data Analysis), by End-Use & by Region - Forecast to 2026

Published: March 2021 | Historical Data: 2017-2020 | Base Year: 2020
SKU: ICI-HC-1271 | Number of Pages: 162 | Category: Biotechnology

The global next generation sequencing services (NGS) market size was valued over USD 1,966.6 million in 2020 and is expected to witness a CAGR of 22.5% during the forecast period. Application of NGS in multiple clinical areas is increasing due to affordable cost. Rising usage of NGS for reliable diagnosis of chronic diseases in a quicker time span, increasing research & development activities, development of advanced instruments, government initiatives for advanced clinical diagnosis, and occurrence of adverse drug reactions are also driving the global market growth. However, quality concerns for large scale sequencing analysis and dearth of adequate trained professionals are expected to hinder the growth.

Next Generation Sequencing (NGS) Services Market

By Sequencing Type

Based on sequencing type, the market is categorized into whole exome, whole genome, and targeted sequencing & resequencing. The targeted sequencing & resequencing is sub-divided into RNA-based sequencing and DNA-based sequencing. In 2020, the targeted sequencing & resequencing segment accounted for a significant revenue share owing to cheaper alternative for investigation of patient illness. Additionally, the specific sequence sample enables precision analysis and biologically relevant information. The whole genome sequencing segment is growing with a lucrative CAGR during the forecast period owing to its success rate for determining all possible variations inclusive of single nucleotide polymorphism, copy number variations, and insertion & deletion of genome in particular sample.

By Application

Based on application, the market is segmented into HLA typing/immune system monitoring, agri-genomics & forensics, metagenomics, epidemiology & drug development, consumer genomics, reproductive health, clinical investigation, and oncology. In 2019, oncology segment accounted for the largest revenue share owing to advent of liquid biopsy techniques and rise in oncology cases globally. Additionally, introduction of preventive screening program is driving the segment’s growth. Consumer genomics is projected to be growing with a lucrative CAGR during the forecast period.

By Process Flow Type

On the basis of process flow type, the market is categorized into pre-sequencing, sequencing, and data analysis. The pre-sequencing segment is divided into NGS automated library preparation, NGS semi-automated library preparation, NGS library preparation kits, and NGS clonal amplification. The data analysis segment is divided into primary, secondary, and tertiary data analysis. In the global market, the sequencing segment is accounted for the largest revenue share in 2020 owing to its wide application in precise disease detection. The data analysis segment is expected to grow at the fastest CAGR during the forecast period.

By End-Use

On the basis of end-use, the market is categorized into clinical research, academic research, hospitals & clinics, biotech & pharma companies, and others. In the global market, the academic research segment is accounted for the largest revenue share in 2020 owing to the large adoption of next generation sequencing technique in institutes and universities for research as well as professional programs and collaboration of medical companies with institutes for clinical diagnosis. The clinical research segment is expected to grow at a significant CAGR during the forecast period as NGS offers reliable, cost-effective and analytically precise results for clinical tests.

Regional Insights

North America was the highest revenue-grossing segment of the global market in 2020 and is projected to maintain its dominance during the forecast period. This is due to the presence of large testing labs and rise in government support for research & development activities. Additionally, the advanced healthcare infrastructure and increasing number of university programs are other factors that will drive the market growth. Asia Pacific market is estimated to grow at the fastest growth rate during the forecast period owing to the increasing number of clinical trials, expanding marketing programs by leading companies, and rising government funding in advancements of genomic sector.

North America Next Generation Sequencing (NGS) Services Market Size (2017-2026), USD Million

North America Next Generation Sequencing (NGS) Services Market

Competitor Insights

Some of the major companies in the NGS services market are Thermo Fisher Scientific Inc. (U.S.), Illumina, Inc. (U.S.), F Hoffman-La Roche Ltd. (Switzerland), Oxford Nanopore Technologies (U.K.), Eurofins (Luxembourg), Genomatix GmbH (Germany), DNASTAR (U.S.), PierianDx, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and PerkinElmer, Inc. (U.S.). Market expansion, improvements in sequencing techniques, investments in R&D, and strategic collaborations are some of the major strategies adopted by the leading players operating in the market.

 

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2017 to 2026. The next generation sequencing (NGS) services market report is categorized into the following segments and subsegments:

Next Generation Sequencing Services (NGS) Market, By Sequencing Type (Revenue, 2017-2026, USD Million)

  • Whole Exome
  • Whole Genome
  • Targeted Sequencing & Resequencing
    • RNA-based
    • DNA-based

Next Generation Sequencing (NGS) Services Market, By Application (Revenue, 2017-2026, USD Million)

  • Clinical Investigation
    • Idiopathic Diseases
    • Infectious Diseases
    • Non-Communicable/Other Diseases
    • Inherited Diseases
  • Oncology
    • Diagnostics and screening
      • Companion diagnostics
      • Oncology Screening
      • Other diagnostics
    • Research Studies
  • Reproductive Health
    • Single Gene Analysis
    • NIPT
    • New-Born/Genetic Screening
    • PGT
  • HLA Typing/Immune System Monitoring
  • Agri-Genomics & Forensics
  • Metagenomics
  • Epidemiology & Drug Development
  • Consumer Genomics

Next Generation Sequencing (NGS) Services Market, By Process Flow Type (Revenue, 2017-2026, USD Million)

  • Pre-Sequencing
    • NGS Automated Library Preparation
    • NGS Semi-Automated Library Preparation
    • NGS Library Preparation Kits
    • NGS Clonal Amplification
  • Sequencing
  • Data Analysis
    • Primary
    • Secondary
    • Tertiary

Next Generation Sequencing (NGS) Services Market, By End-use (Revenue, 2017-2026, USD Million)

  • Clinical Research
  • Academic Research
  • Hospitals & Clinics
  • Biotech & Pharma companies
  • Others

Next Generation Sequencing (NGS) Services Market, By Region (Revenue, 2017-2026, USD Million)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Next Generation Sequencing Services Market Report:

Key Parameters Details
Data Availability 2017-2026
Historical Years 2017-2020
Base Year Considered 2020
Forecast Period 2020-2026
Company Profiles 10
Companies Considered (Across Value Chain) >50
Value Units Value in USD and CAGR in %
Market Segments Sequencing Type, Application, Process Flow Type, and End-Use
Regional Coverage North America (U.S. and Canada), Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe), Asia Pacific (China, Japan, Australia, India, South Korea, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), and the Middle East & Africa (South Africa, Saudi Arabia, Rest of MEA)
Key Market Players Thermo Fisher Scientific Inc. (U.S.), Illumina, Inc. (U.S.), F Hoffman-La Roche Ltd. (Switzerland), Oxford Nanopore Technologies (U.K.), Eurofins (Luxembourg), Genomatix GmbH (Germany), DNASTAR (U.S.), PierianDx, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and PerkinElmer, Inc. (U.S.)
Custom Analysis Customization up to 60 analyst hours

Next Generation Sequencing Services (NGS) Market, By Sequencing Type (Revenue, 2017-2026, USD Million)

  • Whole Exome
  • Whole Genome
  • Targeted Sequencing & Resequencing
    • RNA-based
    • DNA-based

Next Generation Sequencing (NGS) Services Market, By Application (Revenue, 2017-2026, USD Million)

  • Clinical Investigation
    • Idiopathic Diseases
    • Infectious Diseases
    • Non-Communicable/Other Diseases
    • Inherited Diseases
  • Oncology
    • Diagnostics and screening
      • Companion diagnostics
      • Oncology Screening
      • Other diagnostics
    • Research Studies
  • Reproductive Health
    • Single Gene Analysis
    • NIPT
    • New-Born/Genetic Screening
    • PGT
  • HLA Typing/Immune System Monitoring
  • Agri-Genomics & Forensics
  • Metagenomics
  • Epidemiology & Drug Development
  • Consumer Genomics

Next Generation Sequencing (NGS) Services Market, By Process Flow Type (Revenue, 2017-2026, USD Million)

  • Pre-Sequencing
    • NGS Automated Library Preparation
    • NGS Semi-Automated Library Preparation
    • NGS Library Preparation Kits
    • NGS Clonal Amplification
  • Sequencing
  • Data Analysis
    • Primary
    • Secondary
    • Tertiary

Next Generation Sequencing (NGS) Services Market, By End-use (Revenue, 2017-2026, USD Million)

  • Clinical Research
  • Academic Research
  • Hospitals & Clinics
  • Biotech & Pharma companies
  • Others

Next Generation Sequencing (NGS) Services Market, By Region (Revenue, 2017-2026, USD Million)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA
1. Research Methodology
  1.1. Research Objective
  1.2. Study Scope: Market Segments
  1.3. Study Timeframe, Limitations & Currency
  1.4. Domain-Assisted Cognition (DAC) Framework
    1.4.1. Three-stage Research Methodology
      1.4.1.1. Understand Ecosystem
        1.4.1.1.1. Secondary Research
        1.4.1.1.2. Primary Research
        1.4.1.1.3. Internal Repository
      1.4.1.2. Synthesize Information
      1.4.1.2.1. Data Analysis
      1.4.1.2.2. Data Triangulation
      1.4.1.3. Predict/Project Growth
      1.4.1.3.1. Market Size Estimation
       1.4.1.3.1.1. Bottom-up Approach
       1.4.1.3.1.2. Top-down Approach
      1.4.1.3.2. Data Validation
   1.4.2. Two-stage Quality Check Mechanism
     1.4.2.1. Inspection & Reporting
     1.4.2.2. Quality Audit
2. Market Summary
 2.1. Market Definition & Market Landscape
 2.2. Market Segment Snapshot
 2.3. Geographic Market Snapshot
3. Market Dynamics
 3.1. Market Driver Analysis
   3.1.1. Affordability of sequencing technique
   3.1.2. Technological advancement in sequencing
   3.1.3. Increasing awareness for benefits of NGS
   3.1.4. Rising research & development
 3.2. Market Restraint Analysis
   3.2.1. Quality concerns for large scale sequencing analysis
   3.2.2. Dearth of trained professionals
 3.3. Market Opportunities
   3.3.1. Increasing genetic diseases
   3.3.2. Growing healthcare sector in emerging economies
4. Industry Outlook
 4.1. Key Market Trends
 4.2. Value Chain Analysis
 4.3. Porter’s 5 Forces Analysis
 4.4. Pricing Analysis (2017-2020)
 4.5. Product Benchmarking
5. Covid-19 Impact and Deviation Analysis
 5.1. Covid-19 Prevalence Analysis
 5.2. Key Market Trends
 5.3. Market Size Deviation Analysis (2020-2026)
6. Next Generation Sequencing Services Market Size and Forecast, by Sequencing Type (2017-2026), USD Million
 6.1. Whole Exome
 6.2. Whole Genome
 6.3. Targeted Sequencing & Resequencing
  6.3.1. RNA-based
  6.3.2. DNA-based
7. Next Generation Sequencing Services Market Size and Forecast, by Application (2017-2026), USD Million
 7.1. Clinical Investigation
  7.1.1. Idiopathic Diseases
  7.1.2. Infectious Diseases
  7.1.3. Non-Communicable/Other Diseases
  7.1.4. Inherited Diseases
 7.2. Oncology
  7.2.1. Diagnostics and screening
   7.2.1.1. Companion diagnostics
   7.2.1.2. Oncology Screening
   7.2.1.3. Other diagnostics
  7.2.2. Research Studies
 7.3. Reproductive Health
  7.3.1. Single Gene Analysis
  7.3.2. NIPT
  7.3.3. New-Born/Genetic Screening
  7.3.4. PGT
 7.4. HLA Typing/Immune System Monitoring
 7.5. Agri-Genomics & Forensics
 7.6. Metagenomics
 7.7. Epidemiology & Drug Development
 7.8. Consumer Genomics
8. Next Generation Sequencing Services Market Size and Forecast, by Process Flow Type (2017-2026), USD Million
 8.1. Pre-Sequencing
  8.1.1. NGS Automated Library Preparation
  8.1.2. NGS Semi-Automated Library Preparation
  8.1.3. NGS Library Preparation Kits
  8.1.4. NGS Clonal Amplification
 8.2. Sequencing
 8.3. Data Analysis
  8.3.1. Primary
  8.3.2. Secondary
  8.3.3. Tertiary
9. Next Generation Sequencing Services Market Size and Forecast, by End-Use (2017-2026), USD Million
 9.1. Clinical Research
 9.2. Academic Research
 9.3. Hospitals & Clinics
 9.4. Biotech & Pharma companies
 9.5. Others
10. 10. Next Generation Sequencing Services Market, Regional Analysis (2017-2026), USD Million
 10.1. North America
  10.1.1. Introduction
   10.1.1.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.1.1.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.1.1.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.1.1.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
   10.1.1.5. Market Size & Forecast, by Country (2017-2026), USD Million
  10.1.2. U.S.
   10.1.2.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.1.2.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.1.2.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.1.2.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.1.3. Canada
   10.1.3.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.1.3.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.1.3.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.1.3.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
 10.2. Europe
  10.2.1. Introduction
   10.2.1.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.2.1.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.2.1.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.2.1.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
   10.2.1.5. Market Size & Forecast, by Country (2017-2026), USD Million
  10.2.2. Germany
   10.2.2.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.2.2.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.2.2.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.2.2.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.2.3. UK
   10.2.3.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.2.3.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.2.3.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.2.3.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.2.4. France
   10.2.4.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.2.4.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.2.4.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.2.4.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.2.5. Spain
   10.2.5.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.2.5.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.2.5.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.2.5.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.2.6. Italy
   10.2.6.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.2.6.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.2.6.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.2.6.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.2.7. Russia
   10.2.7.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.2.7.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.2.7.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.2.7.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.2.8. Rest of Europe
   10.2.8.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.2.8.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.2.8.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.2.8.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
 10.3. Asia Pacific (APAC)
  10.3.1. Introduction
   10.3.1.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.3.1.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.3.1.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.3.1.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
   10.3.1.5. Market Size & Forecast, by Country (2017-2026), USD Million
  10.3.2. China
   10.3.2.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.3.2.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.3.2.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.3.2.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.3.3. Japan
   10.3.3.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.3.3.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.3.3.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.3.3.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.3.4. India
   10.3.4.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.3.4.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.3.4.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.3.4.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.3.5. Australia
   10.3.5.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.3.5.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.3.5.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.3.5.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.3.6. South Korea
   10.3.6.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.3.6.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.3.6.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.3.6.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.3.7. Rest of Asia Pacific
   10.3.7.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.3.7.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.3.7.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.3.7.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
 10.4. Latin America (LATAM)
  10.4.1. Introduction
   10.4.1.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.4.1.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.4.1.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.4.1.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
   10.4.1.5. Market Size & Forecast, by Country (2017-2026), USD Million
  10.4.2. Brazil
   10.4.2.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.4.2.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.4.2.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.4.2.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.4.3. Mexico
   10.4.3.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.4.3.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.4.3.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.4.3.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.4.4. Argentina
   10.4.4.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.4.4.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.4.4.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.4.4.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.4.5. Rest of LATAM
   10.4.5.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.4.5.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.4.5.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.4.5.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
 10.5. Middle East & Africa (MEA)
  10.5.1. Introduction
   10.5.1.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.5.1.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.5.1.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.5.1.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
   10.5.1.5. Market Size & Forecast, by Country (2017-2026), USD Million
  10.5.2. South Africa
   10.5.2.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.5.2.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.5.2.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.5.2.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.5.3. Saudi Arabia
   10.5.3.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.5.3.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.5.3.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.5.3.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
  10.5.4. Rest of MEA
   10.5.4.1. Market Size & Forecast, by Sequencing Type (2017-2026), USD Million
   10.5.4.2. Market Size & Forecast, by Application (2017-2026), USD Million
   10.5.4.3. Market Size & Forecast, by Process Flow Type (2017-2026), USD Million
   10.5.4.4. Market Size & Forecast, by End-Use (2017-2026), USD Million
11. Competitor Analysis
 11.1. Market Player Comparison
 11.2. Product-wise Player Mapping
 11.3. Region-wise Player Mapping
 11.4. Market Share Analysis
 11.5. Market Position Analysis
 11.6. Recent Development Analysis
12. Company Profiles
 12.1. Thermo Fisher Scientific Inc. (U.S.)
  12.1.1. Company Overview
  12.1.2. Company Financials
  12.1.3. Product Portfolio
  12.1.4. Recent Developments
 12.2. Illumina, Inc. (U.S.)
  12.2.1. Company Overview
  12.2.2. Company Financials
  12.2.3. Product Portfolio
  12.2.4. Recent Developments
 12.3. F Hoffman-La Roche Ltd. (Switzerland)
  12.3.1. Company Overview
  12.3.2. Company Financials
  12.3.3. Product Portfolio
  12.3.4. Recent Developments
 12.4. Oxford Nanopore Technologies (U.K.)
  12.4.1. Company Overview
  12.4.2. Company Financials
  12.4.3. Product Portfolio
  12.4.4. Recent Developments
 12.5. Eurofins (Luxembourg)
  12.5.1. Company Overview
  12.5.2. Company Financials
  12.5.3. Product Portfolio
  12.5.4. Recent Developments
 12.6. Genomatix GmbH (Germany)
  12.6.1. Company Overview
  12.6.2. Company Financials
  12.6.3. Product Portfolio
  12.6.4. Recent Developments
 12.7. DNASTAR (U.S.)
  12.7.1. Company Overview
  12.7.2. Company Financials
  12.7.3. Product Portfolio
  12.7.4. Recent Developments
 12.8. PierianDx, Inc. (U.S.)
  12.8.1. Company Overview
  12.8.2. Company Financials
  12.8.3. Product Portfolio
  12.8.4. Recent Developments
 12.9. Bio-Rad Laboratories, Inc. (U.S.)
  12.9.1. Company Overview
  12.9.2. Company Financials
  12.9.3. Product Portfolio
  12.9.4. Recent Developments
 12.10. PerkinElmer, Inc. (U.S.)
  12.10.1. Company Overview
  12.10.2. Company Financials
  12.10.3. Product Portfolio
  12.10.4. Recent Developments
(Note: Financials are captured for public listed companies)

Key questions addressed by the research report-

  1. What are the current market trends and future market forecast from 2020 to 2026 for next generation sequencing services market?
  2. What are the market dynamics and probable opportunities for market players during the forecast period?
  3. Initiatives undertaken my market players to address the COVID-19 impact to sustain in the competitive market.
  4. Which geographies have immense opportunities in different segments of the next generation sequencing services market?
  5. What are the recent strategies adopted by market players such as product launch, partnership, agreement, collaboration, merger & acquisition, and geographical expansion?


    Have any question? Check your free sample before purchase or connect with our expert.

    Additional information

    Licensing Types

    , , ,

    Enquire about Next Generation Sequencing (NGS) Services Market Analysis by Sequencing Type, by Application (Clinical Investigation, Oncology, Immune System Monitoring), by Process Flow Type (Pre-Sequencing, Sequencing, Data Analysis), by End-Use & by Region - Forecast to 2026